老虎证券

美股详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Can-Fite Biopharma Ltd

1.04
-0.0500-4.59%
盘后：1.040.0003+0.03%19:18 EDT
成交量：11.24万
成交额：11.77万
市值：1,336.72万
市盈率：-0.96
高：1.06
开：1.06
低：1.03
收：1.09
数据加载中...
总览公司新闻公告
2021/03/25

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/09

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/29

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/11/30

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/10/07

SEC问询函

CORRESP [Cover] - Correspondence
2020/08/27

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/07/22

SEC问询函

CORRESP [Cover] - Correspondence
2020/07/10

招股说明书

F-1 - Registration statement for certain foreign private issuers
2020/06/19

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/06/19

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/06/01

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/07

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/06

SEC问询函

CORRESP [Cover] - Correspondence
2020/04/06

SEC问询函

CORRESP [Cover] - Correspondence
2020/04/02

非美公司披露报告

6-K/A [Amend] - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/01

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/27

招股说明书

F-1 - Registration statement for certain foreign private issuers
更多